611 related articles for article (PubMed ID: 27137106)
1. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Baskind NE; Balen AH
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
Balen A
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
[TBL] [Abstract][Full Text] [Related]
4. Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.
Wang F; Zhang ZH; Xiao KZ; Wang ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):699-704. PubMed ID: 29125115
[TBL] [Abstract][Full Text] [Related]
5. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
Cheung AP; Lu JK; Chang RJ
Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
8. La esteroidogénesis en el síndrome de ovarios poliquísticos.
Ventura-Arizmendi E; Hernández-Valencia M
Gac Med Mex; 2019; 155(2):184-190. PubMed ID: 31056603
[TBL] [Abstract][Full Text] [Related]
9. Reproductive endocrinology of adolescent polycystic ovary syndrome.
Shayya R; Chang RJ
BJOG; 2010 Jan; 117(2):150-5. PubMed ID: 20002395
[TBL] [Abstract][Full Text] [Related]
10. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
11. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS).
Li Y; Chen C; Ma Y; Xiao J; Luo G; Li Y; Wu D
Life Sci; 2019 Jul; 228():167-175. PubMed ID: 31029778
[TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
13. Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome.
Dafopoulos K; Venetis C; Pournaras S; Kallitsaris A; Messinis IE
Fertil Steril; 2009 Oct; 92(4):1378-1380. PubMed ID: 19467538
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome in adolescent girls.
Baldauff NH; Witchel SF
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine control in polycystic ovary-like syndrome.
Schoemaker J
Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
[TBL] [Abstract][Full Text] [Related]
17. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.
Barnes RB
J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411
[TBL] [Abstract][Full Text] [Related]
19. Pathological pulses in PCOS.
Coyle C; Campbell RE
Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
[TBL] [Abstract][Full Text] [Related]
20. [Etiopathogenesis of the polycystic ovary syndrome].
Sciarra F; Toscano V; Tosti-Croce C
Minerva Endocrinol; 1987; 12(3):183-90. PubMed ID: 3116379
[No Abstract] [Full Text] [Related]
[Next] [New Search]